Balaji Amines Ltd
BALAMINESBalaji Amines Ltd is strength at full price. The numbers are improving — and a P/E at the 97th percentile of its own range says the market knows.
The sharpest disagreement: the engine is strong, but at the 97th percentile of its own range you are paying full price for it.
The price is in a confirmed uptrend (8 weeks in) while the P/E sits at the 97th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +62.5% year on year, and 138% of the last 3 years' profit arrived as cash. What settles it: whether the earnings grow into the multiple.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Balaji Amines Ltd trades at ₹2,289, in a confirmed uptrend and 8 weeks into that stage. That is +46.0% against its own 200-day average. It sits at 91% of a 52-week range of ₹1,001 to ₹2,415. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 19 straight weeks.
Today the stock is in a confirmed uptrend — week 8 of stage 2, confirmed. At ₹2,289 it trades +46.0% versus its 200-day average and sits at 91% of its 52-week range (₹1,001–₹2,415).
Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +1,597% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 19 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 97th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Balaji Amines Ltd trades at 42.2× P/E, at the pricey end of its own range (97th percentile). Its long-run median P/E is 23.8×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 42.2× is at the pricey end of its own range (97th percentile), against a long-run median of 23.8× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +6.1% against a +29.9% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the −4.7%/yr price move, ~−6.8%/yr came from earnings growth and ~+2.1 pp from the multiple (expanding); over 10y, of the +24.1%/yr price move, ~+11.2%/yr came from earnings growth and ~+12.9 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 25% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Balaji Amines Ltd reads as improving on its fundamental arc. Improving — profit growth bottomed 4 quarters ago at −44.4% and has held its recovery at +62.5% (single-quarter readings), ROCE slipping at 11.0%. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +2.2% | −15.4% | +1.6% | +8.3% |
| Profit | +6.3% | −25.3% | −7.0% | +11.3% |
| EPS | +6.1% | −19.9% | −6.8% | +11.2% |
| Share price | +29.9% | +1.1% | −4.7% | +24.1% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
60.7/100 — rank 3 of 20 in Chemicals - Organic · 83% evidence confidence
Balaji Amines Ltd scores 60.7 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 22 + 14.2 + 5.9 + 18.6 = 60.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Balaji Amines Ltd reported ₹395 Cr of revenue in the Mar 26 quarter, +11.9% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 8.3% a year. The last full year, FY26, came in at ₹1,419 Cr. The last four reported quarters add to ₹1,425 Cr.
Balaji Amines Ltd reported ₹395 Cr of revenue in the Mar 26 quarter, +11.9% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 8.3% a year. The last full year, FY26, came in at ₹1,419 Cr. The last four reported quarters add to ₹1,425 Cr.
FY26 revenue came in at ₹1,419 Cr (+2.2% on the year), capping 10 years at 8.3% compound. The latest quarter (Mar 26) printed ₹395 Cr, +11.9% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +2.3% growth against the decade's 8.3% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +1.9% over the last 4 quarters against −6.8%/yr over the last 8 — accelerating; TTM profit +7.6% vs −14.4%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 24.0% this quarter (+7.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Balaji Amines Ltd's operating margin is 24.0% in the Mar 26 quarter, +7.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 15.0% to 29.0%. The current quarter sits inside that band.
Balaji Amines Ltd's operating margin is 24.0% in the Mar 26 quarter, +7.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 15.0% to 29.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 24.0%, +7.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 15.0%–29.0%.
Why the margin moved: operating margin went +6.9 pp year on year while gross margin went +0.1 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
→ Margins held — did that reach the bottom line? Next: profit +62.5% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Balaji Amines Ltd earned ₹65.0 Cr of net profit in the Mar 26 quarter, +62.5% year on year. Full-year FY26 profit was ₹169 Cr. The 10-year compound rate is 11.3%. That is 16.5% of the quarter's revenue. The same quarter a year earlier earned ₹40.0 Cr.
Balaji Amines Ltd earned ₹65.0 Cr of net profit in the Mar 26 quarter, +62.5% year on year. Full-year FY26 profit was ₹169 Cr. The 10-year compound rate is 11.3%. That is 16.5% of the quarter's revenue. The same quarter a year earlier earned ₹40.0 Cr.
Mar 26 profit was ₹65.0 Cr, +62.5% year on year. On the full year, FY26 printed ₹169 Cr (+6.3%), and the 10-year compound rate is 11.3%.
Why profit moved: revenue contributed +11.9% and the margin +7.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +8.3% vs revenue +2.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
→ Profit rose — but did the cash follow? Next: 138% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 138% of Balaji Amines Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹184 Cr of operating cash against ₹169 Cr of profit. After ₹370 Cr of capital spending, ₹−186 Cr was left as free cash.
FY26: operating cash of ₹184 Cr against reported profit of ₹169 Cr, leaving free cash of ₹−186 Cr after ₹370 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 138% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 138%: the cash cycle stretched 59 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 5.4× depreciation over three years, so the next section's job is to check what that build-out is buying.
→ So follow the cash to where it goes. Next: ₹811 Cr of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Balaji Amines Ltd's cash conversion cycle runs 163 days in FY26, up from 104 days in FY21. Capital spending ran ₹811 Cr over the last 3 years. At FY26 sales of ₹1,419 Cr each day of that cycle holds about ₹3.9 Cr, so roughly ₹634 Cr sits inside the business at any moment.
FY26: debtors at 89 days, inventory at 113 days — roughly 3.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 163 days, looser than FY21's 104.
The full loop: cash goes out to suppliers and production on day 0; stock waits 113 days to sell; customers pay about 89 days after that; and suppliers themselves are paid at 39 days — netting out to the 163-day cycle.
In money terms: at FY26 sales of ₹1,419 Cr, each day of the cycle holds about ₹3.9 Cr — so the 163-day loop keeps roughly ₹634 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹811 Cr over the last 3 fiscal years against ₹149 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹512 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 11%.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Balaji Amines Ltd earns a ROCE of 11% in FY26. That is up from a trough of 11% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 11.9% net margin on 0.52× asset turns.
FY26 ROCE is 11%, recovered from a FY25 trough of 11% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 11.9% net margin × 0.52× asset turns × 1.39× balance-sheet leverage ≈ 8.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 25% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.07.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Balaji Amines Ltd carries ₹133 Cr of borrowings against ₹1,976 Cr of equity in FY26, a debt-to-equity of 0.07. Operating profit covers the interest bill 53×. Over 5 years borrowings went from ₹127 Cr to ₹133 Cr. Capital spending ran ₹811 Cr across the last 3 of those years.
FY26: borrowings of ₹133 Cr against equity of ₹1,976 Cr — a debt-to-equity of 0.07. Operating profit covers the interest bill 53×. Over 5 years borrowings went from ₹127 Cr to ₹133 Cr while capital spending ran ₹811 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 25% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
→ Who owns this, and are they adding or leaving? Next: Foreign institutions cut 1.9 points over 8 quarters.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 1.9 points of Balaji Amines Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 3.2% of the company. Promoters moved +0.9 points over the same window, to 54.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −1.9 points over 8 quarters to 3.2%; Promoters: +0.9 points over 8 quarters to 54.6%; Domestic institutions: +0.0 points over 8 quarters to 1.6%.
🚨 Why the register moved: foreign institutions drove it (−1.9 points), absorbed on the other side by promoters (+0.9 points) — distribution into the market’s bid.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Balaji Amines Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Balaji Amines Ltd this page | 42.2× | ₹7,046 Cr | Improving | |||
| BASF India Ltd | 38.4× | ₹15,887 Cr | No read | |||
| Fine Organic Industries Ltd | 35.9× | ₹14,804 Cr | Improving | |||
| Elantas Beck India Ltd | 50.3× | ₹7,346 Cr | Mixed | |||
| Laxmi Organic Industries Ltd | 63.2× | ₹5,053 Cr | Mixed | |||
| Foseco India Ltd | 39.0× | ₹3,805 Cr | — | — | — | — |
| Citurgia Biochemicals Ltd | — | ₹1,884 Cr | No read | |||
| Nitta Gelatin India Ltd | 13.5× | ₹1,489 Cr | Mixed | |||
| Oriental Aromatics Ltd | 379.0× | ₹1,255 Cr | Mixed | |||
| Jyoti Resins and Adhesives Ltd | 14.3× | ₹997 Cr | Topping out | |||
| Sigachi Industries Ltd | 29.9× | ₹974 Cr | Turning around | |||
| Fairchem Organics Ltd | 157.0× | ₹967 Cr | Turning around | |||
| Sacheerome Ltd | 33.3× | ₹946 Cr | — | — | — | — |
| Indo Amines Ltd | 11.8× | ₹940 Cr | Consistent | |||
| Gem Aromatics Ltd | 651.0× | ₹930 Cr | No read | |||
| Shri Ahimsa Naturals Ltd | 31.1× | ₹904 Cr | — | — | — | — |
| Valiant Organics Ltd | 25.4× | ₹737 Cr | No read | |||
| OCCL Ltd | 14.6× | ₹724 Cr | No read | |||
| Shree Ganesh Remedies Ltd | 35.1× | ₹636 Cr | Deteriorating | |||
| Valiant Organics Ltd | 33.0× | ₹600 Cr | No read | |||
| GFL Ltd | 11.0× | ₹494 Cr | No read |
Frequently asked questions
What is Balaji Amines Ltd's share price today?
Balaji Amines Ltd trades at ₹2,289, +29.9% over the past year. The company is valued at ₹7,046 Cr. The stock sits at 91% of its 52-week range of ₹1,001–₹2,415, +46.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 8 weeks in. — as of 24 July 2026.
What were Balaji Amines Ltd's latest quarterly results?
Balaji Amines Ltd reported revenue of ₹395 Cr and net profit of ₹65.0 Cr for the Mar 26 quarter. Revenue rose 11.9% and profit rose 62.5% year on year. Earnings per share were ₹19.51. The operating margin was 24.0%, 7.0 pp higher than a year earlier. — as of 24 July 2026.
What is Balaji Amines Ltd's revenue?
Balaji Amines Ltd reported revenue of ₹395 Cr in the Mar 26 quarter, +11.9% year on year. For the full FY26 fiscal year, revenue was ₹1,419 Cr (+2.2%). Over the last 10 years revenue compounded at 8.3% a year. — as of 24 July 2026.
What is Balaji Amines Ltd's profit?
Balaji Amines Ltd earned ₹65.0 Cr of net profit in the Mar 26 quarter, +62.5% year on year. Full-year FY26 profit was ₹169 Cr. The operating margin ran 24.0% in the latest quarter. — as of 24 July 2026.
What is Balaji Amines Ltd's market cap?
Balaji Amines Ltd's market capitalisation is ₹7,046 Cr at a share price of ₹2,289. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is Balaji Amines Ltd's P/E ratio?
Balaji Amines Ltd trades at a P/E of 42.2×, at the 97th percentile of its own 10-year range, against a long-run median of 23.8×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does Balaji Amines Ltd pay a dividend?
Yes — Balaji Amines Ltd's dividend payout was 21% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is Balaji Amines Ltd overvalued?
On its own history, Balaji Amines Ltd looks expensive against its own history: its P/E of 42.2× sits at the 97th percentile of its 10-year range (long-run median 23.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
Is Balaji Amines Ltd growing?
Yes — Balaji Amines Ltd is growing: latest-quarter revenue +11.9% year on year, profit +62.5%, and the margin +7.0 pp at 24.0%. The 10-year compound rates are 8.3% (revenue) and 11.3% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is Balaji Amines Ltd performing?
Balaji Amines Ltd is in a confirmed uptrend, 8 weeks in. Its latest quarter's revenue rose 11.9% and profit rose 62.5% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 19 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is Balaji Amines Ltd in?
Improving — profit growth bottomed 4 quarters ago at −44.4% and has held its recovery at +62.5% (single-quarter readings), ROCE slipping at 11.0%. The read comes from the last 12 quarters of growth (revenue growth +11.9% latest, profit growth +62.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is Balaji Amines Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 8 of stage 2), trading +46.0% versus its 200-day average and at 91% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Balaji Amines Ltd beating the market?
On recent form, yes — Balaji Amines Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 19 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +1,597% against the NIFTY 500's +274% — ahead of the index over the full window. — as of 24 July 2026.
Will Balaji Amines Ltd's share price go up?
This page publishes no price forecast for Balaji Amines Ltd. What it measures instead: the share price is ₹2,289, the price is in a confirmed uptrend 8 weeks in. Its P/E of 42.2× sits at the 97th percentile of its own 10-year range. — as of 24 July 2026.
Who owns Balaji Amines Ltd?
Promoters hold 54.6% of Balaji Amines Ltd, foreign institutions 3.2%, domestic institutions 1.6% and the public 40.7% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 1.9 points over 8 quarters. — as of 24 July 2026.
Does Balaji Amines Ltd have too much debt?
No — Balaji Amines Ltd's debt-to-equity is 0.07, and operating profit covers the interest bill 53×. FY26 borrowings were ₹133 Cr against equity of ₹1,976 Cr. The returns on this page are earned, not borrowed — as of 24 July 2026.
What is Balaji Amines Ltd's capex?
Balaji Amines Ltd spent ₹811 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹370 Cr, with ₹512 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is Balaji Amines Ltd's cash flow?
Balaji Amines Ltd generated ₹184 Cr of operating cash flow in FY26 and ₹−186 Cr of free cash flow after ₹370 Cr of capital spending. Reported profit that year was ₹169 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Balaji Amines Ltd's profit real cash?
Yes — over the last 3 fiscal years, 138% of Balaji Amines Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹184 Cr against reported profit of ₹169 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is Balaji Amines Ltd in its business cycle?
Balaji Amines Ltd's FY26 operating margin was 19.0%, against a 13-year band of 15.0%–29.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 24.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Balaji Amines Ltd story?
The sharpest disagreement: the engine is strong, but at the 97th percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Balaji Amines Ltd a stock worth studying right now?
This is not investment advice. The machine read: Balaji Amines Ltd is strength at full price. The numbers are improving — and a P/E at the 97th percentile of its own range says the market knows. The sharpest open question: whether the earnings grow into the multiple. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.